期刊文献+

紫杉醇脂质体注射液初始化疗后非小细胞肺癌组织病理学变化 被引量:1

The histopathological changes of non-small cell lung cancer treated with paclitaxel liposome injection as primarily chemotherapy
暂未订购
导出
摘要 目的探讨紫杉醇脂质体注射液初始化疗后非小细胞肺癌组织病理学变化。方法选取40例临床诊断为非小细胞肺癌IIIB患者,随机分为2组,每组各20例。对照组:立即行手术治疗。试验组:术前1个月应用紫杉醇脂质体注射液初始化疗后手术;应用HE染色、电镜方法分别观察2组患者病理学改变。结果(1)2组病理学疗效评价:试验组I、II级共13例,明显高于对照组的0例,而III、IV级分别为3例、4例,明显少于对照组的6例、14例,疗效评价差异有统计学意义(P<0.05);试验组较对照组瘤细胞坏死明显,细胞空泡变性增多,核固缩、凝固性坏死显著。肿瘤组织及其周围组织中可见大量淋巴细胞和嗜酸性细胞浸润;(2)2组生存质量、T细胞亚群变化及其不良反应差异均无统计学意义(P>0.05)。(3)患者临床疗效与年龄、性别之间无相关性(r=0.284,P>0.05),与肿瘤类型密切相关(P<0.05)。结论IIIB期非小细胞肺癌患者应用紫杉醇脂质体注射液初始化疗后,可获得较好的组织病理学疗效评价。 Objective To analyze the histopathological features of non-small cell lung cancer treatment with paclitaxel liposome injection as primarily chemotherapy. Methods Consecutive selected 40 cases with non-small cell lung cancer at grade ⅢB , were divided into control group and treatment group randomly. The surgery was executed immediately in control group, while the paclitaxel liposome injection was administrated as primarily chemotherapy for 1 month in treatment group. The pathological analysis were compared between two groups, with HE staining and electron microscope methods. Results ( 1 ) There were 13 cases with grade Ⅰ,Ⅱ and 3,4 cases with grade Ⅲ, Ⅳ non-small cell lung cancer in treatment group,while there were 0 cases with grade Ⅰ,Ⅱand 6, 14 cases with grade Ⅲ, Ⅳ. The therapeutic effect showed statistical significant difference between two groups ( P 〈 0.05 ). In addition, the necrosis of tumor cells was obvious in treatment, and improving cellular vacuolar degeneration, pyknosis and coagulation necrosis was obvious too. There was large amount of lymphocytes and acidophilic cellular infihration around tumor tissue. ( 2 ) The survival ratio, T cell subtype ratio and side effect between two groups had no difference ( P 〉 0.05 ). ( 3 ) The therapeutic effect bad no relationship with the patients'gender and age ( r =0.284, P 〉0.05) ,while had closely correlation with type of the tumor ( P 〈 0.05 ). Conclusion It could inhibit tumor growth by primary chemothera py with paclitaxd liposome, and it worthy to applying in clinical treatment.
出处 《疑难病杂志》 CAS 2009年第7期394-396,F0003,共4页 Chinese Journal of Difficult and Complicated Cases
关键词 非小细胞肺癌 紫杉醇脂质体注射液 初始化疗 病理学 Non-small cell lung cancer Paclitaxel liposome injection Primarily chemotherapy Pathology
  • 相关文献

参考文献13

  • 1Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in reseetable stage IIIA non-small-cell lung cancer[ J]. Lung Cancer,1998,21 ( 1 ) :145.
  • 2Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer:a 7-year assessment of a randomized controlled trial [ J ]. Lung Cancer, 1999 ;26 ( 1 ) :7-14.
  • 3Pezzetta E,Stupp R, Zouhair A, et al. Comparison of neoadjuvant cisplatin-based chemotherapy versus radio-chemotherapy followed by resection for stage III N2, NSCLC [ J]. Eur J Cardiothorac Surg, 2005,276 (19): 1 092-1 101.
  • 4Park BB, Park JO, Kim H, et al. Is trimodality approach better then bimodality in stage IIIA, N positive non-small cell lung cancer [ J ]. Lung Cancer,2006,533 ( 5 ) :323-327.
  • 5韩梅,吕平,何其华,袁兰,马士良,陶家平.T细胞亚群CD4测定方法的研究[J].生物化学与生物物理进展,2000,27(2):218-220. 被引量:2
  • 6易祥华,张容轩,丁嘉安,高文,马前立,钟慈声.非小细胞肺癌新辅助化疗后的临床病理学研究[J].中国肺癌杂志,2003,6(2):124-128. 被引量:11
  • 7Wani MC,Taylor HL,Wall ME, et al. Plant anti-tumor agent (IV) : the isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia[ J ]. Am C hem Soc J,1971,9 (15) :2 325.
  • 8方起程,韩锐,陈未名,何小庆,丁怡,程青,方唯硕,刘红岩,孙迪安,顾建桥.抗肿瘤新药紫杉醇及其注射液的研究和开发[J].中国肿瘤,1997,6(6):22-23. 被引量:11
  • 9Strieth S, Eichhorn ME,Sauer B,et al. Neovascular targeting chemotherapy:encapsulation of paclitaxel in cationic liposomes impairs functional tumor rnicrovasculature [ J ]. Int J Cancer,2004,110 ( 1 ) : 117-124.
  • 10Schmitt-Sody M, Strieth S, Krasnici S, et al. Neovascular targeting therapy:paclitaxelencap sulated in cationic lip osomes improves antitumoral efficacy[J]. Clin Cancer Res,2003,9(6) :2 335-2 341.

二级参考文献3

共引文献21

同被引文献15

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部